Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CPC Biotech is an Italian biotechnology company specializing in the development and production of high-quality enzymes and microbiology products for the pharmaceutical and food industries. The company is widely recognized for its expertise in producing beta-lactamases, which are used to neutralize antibiotics in sterility testing and environmental monitoring. Their product portfolio includes a range of enzymes for antibiotic inactivation, as well as specialized media and diagnostic tools. CPC Biotech serves a global market, providing critical reagents that ensure the safety and compliance of pharmaceutical manufacturing processes. The company focuses on innovation in enzyme stabilization and recombinant protein production to meet rigorous regulatory standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CPC Biotech.